BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapyZeyu Peng, Xiaodong F. Liu,Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Mark Z. MaCANCER RESEARCH(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要